Figure 4.
PFS and OS of PET-2+patients in the H10 trial. PFS (A) and OS (B) in patients PET+ after 2×ABVD randomly assigned to either standard treatment with ABVD plus INRT or treatment with BEACOPPescalated plus INRT. esc, escalated. Reprinted from André et al6 with permission.